All Type of News
Korean drugmakers eye growth through OTC products
With the government’s plan to allow supermarkets to sell OTC products in the near future, Korean pharmaceutical firms set about shaking up their existing organizations and paving the way for its future.
They aim to...
Pharmaceutical wholesalers facing survival game
Many drug wholesalers have been spending a considerable amount of time taking up their market share with a “back-margin” policy, while foreign capitals have threatened to strengthen their presence in the local logisti...
Credit card payment should exceed 10,000 won in transaction amount
The government and the ruling Grand National Party (GNP) are moving to allow retailers to refuse plastic for transactions worth less than 10,000 won. It is apparently designed to appease disgruntled credit card firms ...
New Hanmi advisor starts work
Hanmi Pharm said that Kim Chung-soo Mellve, former president of Korea Pharmaceutical Manufacturers Association, has been named as its new advisor.
Kim is starting work at Hanmi Pharm from March 18, according to the...
OTC selling should be allowed at supermarkets
People may buy digestives at supermarkets, according to Strategy and Finance Minister Yoon Jeung-hyun who cited an example to enhance competitiveness in the services sector.
“If OTCs may be freely sold at supermark...
Samil, Boehringer Ingelheim sign exclusive distribution agreement over Mobic cap.
Samil Pharm has signed an exclusive distribution agreement with Boeringer Ingelheim Korea to supply Mobic (meloxicma) in the domestic market.
“We are excited to enter into this collaboration with Boehringer Ingelhe...
Hanmi releases dexibuprofen ER tablets
Hanmi Pharm said it has newly launched an extended release form of dexibuprofen 300 mg tablets for relief of sign and symptoms of osteoarthritis, rheumatoidal disorders such as osseous rheumatism, ankylosing spondilit...
Daewoong launches Fiblast spray
Daewoong Pharm said it has launched Fiblast Spray (trafermin) for treatment of skin ulcers and decubitus.
The active ingredient in Fiblast Spray is recombinant basic Fibroblast Growth Factor (FGF), which the Japane...
KIT to conduct large-scale preclinical tests over antisense oligonucleotides
The Korea Institute of Toxicology (KIT) said on March 16 that KIT will carry out its preclinical studies for the US based ISIS Pharmaceuticals Inc’s antisense oligonucleotides (ASO) using non-human primates.
Both o...
New CEOs in pharmaceutical industry facing challenge
Local pharmaceutical firms are likely to face their biggest challenges this year due to the deepening economic downturn; so too will be heads of the leading pharmaceutical firms.
Experts said a number of newly app...
